This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Celgene Corporation. Active years: 2022-2025.
Company Filing History:
Years Active: 2022-2025
Title: Fabien Boulineau: Innovator in Pharmaceutical Compositions
Introduction
Fabien Boulineau is a notable inventor based in Summit, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions and methods.
Latest Patents
Fabien Boulineau holds 2 patents related to pharmaceutical compositions. His latest patents focus on compositions comprising (S)-2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro-4-((3-morpholinoazetidin-1-yl)methyl)benzyl)amino)isoindoline-1,3-dione. These patents detail methods of preparing and using these pharmaceutical compositions, which include oral dosage formulations and various forms of the compound, such as enantiomers and pharmaceutically acceptable salts.
Career Highlights
Fabien Boulineau is currently employed at Celgene Corporation, where he continues to advance his research and development efforts in the pharmaceutical industry. His work has contributed to the creation of effective therapeutic solutions.
Collaborations
He collaborates with esteemed colleagues, including Sreenivas S Bhat and Donna Carroll, to further enhance the impact of his innovations in the pharmaceutical sector.
Conclusion
Fabien Boulineau's work exemplifies the importance of innovation in pharmaceuticals, showcasing his dedication to improving health outcomes through his inventions.